Drug search by name

Dinutuximab Intravenous and Myelosuppression

Result of checking the interaction of drug Dinutuximab Intravenous and disease Myelosuppression for safety when used together.

Check result:

Dinutuximab Intravenous <> Myelosuppression

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Myelosuppression has been reported during administration of dinutuximab. In a clinical study, severe thrombocytopenia, anemia, neutropenia occurred more frequently in patients treated with dinutuximab/13-cis-retinoic acid group compared to those treated with 13-cis-retinoic acid alone. Therapy with rituximab should be administered cautiously in patients with severe bone marrow suppression. Clinical monitoring of hematopoietic function is recommended during therapy.

Dinutuximab Intravenous

Generic Name: dinutuximab

Brand Name: Unituxin

Synonyms: Dinutuximab

What is Dinutuximab Intravenous?